Showing results (41-50 of 50) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Journal of Crohn'S & Colitis|April 10, 2021
Dose optimisation for Loss of Response to Vedolizumab- Pharmacokinetics and Immune MechanismsBella Ungar, Karin Malickova, Jurij Hanžel, et al.Journal of Crohn'S & Colitis|June 27, 2025
Gaps between European Crohn's and Colitis Organisation quality standards of care and the real world on diagnosis and monitoring inflammatory bowel disease across Europe: results from the E-QUALITY surveyGionata Fiorino, Catarina Fidalgo, Michel Adamina, et al.Journal of Crohn'S & Colitis|June 13, 2025
Gaps between European Crohn's Colitis Organisation quality standards of care and the real world on structure of IBD units across Europe: results from E-QUALITY surveyGionata Fiorino, Alissa Walsh, Michel Adamina, et al.The Lancet. Gastroenterology & Hepatology|January 13, 2022
Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectivesKonstantinos Papamichael, Waqqas Afif, David Drobne, et al.European Journal of Gastroenterology & Hepatology|April 16, 2024
Biological treatment approach to inflammatory bowel disease is similar in academic and nonacademic centres - prime time for decentralisation of inflammatory bowel disease care?Katja Tepeš, Jurij Hanžel, David Štubljar, et al.Inflammatory Bowel Diseases|June 8, 2017
Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective StudyUri Kopylov, Konstantinos Papamichael, Konstantinos Katsanos, et al.Alimentary Pharmacology & Therapeutics|May 16, 2020
Effectiveness of ustekinumab dose escalation in Crohn's disease patients with insufficient response to standard-dose subcutaneous maintenance therapyUri Kopylov, Jurij Hanzel, Claire Liefferinckx, et al.Journal of Clinical Medicine|July 2, 2021
Effectiveness of Third-Class Biologic Treatment in Crohn's Disease: A Multi-Center Retrospective Cohort StudyAhmad Albshesh, Joshua Taylor, Edoardo V Savarino, et al.Inflammatory Bowel Diseases|August 5, 2023
Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis: A Retrospective Worldwide Multicenter Collaborative StudyTamás Resál, Péter Bacsur, Csilla Keresztes, et al.Journal of Crohn'S & Colitis|July 27, 2022
Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European StudyHenit Yanai, Anna Kagramanova, Oleg Knyazev, et al.Pageof 5